首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
【24h】

Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.

机译:生物制药生产的制造,法规和商业挑战:芬兰的观点。

获取原文
获取原文并翻译 | 示例
           

摘要

Biopharmaceuticals product development is a broad and multidisciplinary field. Science and technology are combined with new manufacturing, regulatory and commercial challenges. However, although there is ample literature on the molecular biology and biochemistry of products, the implementation of processes from test tube to commercial scale has not received similar attention. Consequently, the present study aims to highlight, from practical point of view, some of the key issues involved with manufacturing technologies of biopharmaceuticals at a commercial scale. Regulatory requirements and investments are also addressed based on the practical experiences of start-up and small companies. Finland is used as a case-example of such companies as this is a EU-member state with strong technological growth and rapidly increasing number of biotech companies.
机译:生物制药产品的开发是一个广泛的多学科领域。科学技术与新的制造,法规和商业挑战相结合。然而,尽管关于产品的分子生物学和生物化学的文献很多,但是从试管到商业规模的过程的实施并没有受到类似的关注。因此,本研究旨在从实践的角度强调商业规模生物制药生产技术涉及的一些关键问题。监管要求和投资也根据初创公司和小公司的实践经验来解决。芬兰以此类公司为例,因为这是一个欧盟成员国,技术发展强劲,生物技术公司数量迅速增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号